These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26946333)

  • 1. Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample.
    VanWagner LB; Serper M; Kang R; Levitsky J; Hohmann S; Abecassis M; Skaro A; Lloyd-Jones DM
    Am J Transplant; 2016 Sep; 16(9):2684-94. PubMed ID: 26946333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of pretransplant cardiac risk factor burden and major adverse cardiovascular events in liver transplant recipients over time.
    Harrington CR; Levy P; Cabrera E; Gao J; Gregory DL; Padilla C; Crespo G; VanWagner LB
    Liver Transpl; 2023 Jun; 29(6):581-590. PubMed ID: 36724875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis.
    Molnar MZ; Joglekar K; Jiang Y; Cholankeril G; Abdul MKM; Kedia S; Gonzalez HC; Ahmed A; Singal A; Bhamidimarri KR; Aithal GP; Duseja A; Wong VW; Gulnare A; Puri P; Nair S; Eason JD; Satapathy SK;
    Liver Transpl; 2019 Mar; 25(3):399-410. PubMed ID: 30369023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium.
    Kwong AJ; Devuni D; Wang C; Boike J; Jo J; VanWagner L; Serper M; Jones L; Sharma R; Verna EC; Shor J; German MN; Hristov A; Lee A; Spengler E; Koteish AA; Sehmbey G; Seetharam A; John N; Patel Y; Kappus MR; Couri T; Paul S; Salgia RJ; Nhu Q; Frenette CT; Lai JC; Goel A;
    Liver Transpl; 2020 Nov; 26(11):1492-1503. PubMed ID: 33047893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events.
    Vanwagner LB; Bhave M; Te HS; Feinglass J; Alvarez L; Rinella ME
    Hepatology; 2012 Nov; 56(5):1741-50. PubMed ID: 22611040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    VanWagner LB; Lapin B; Skaro AI; Lloyd-Jones DM; Rinella ME
    Liver Int; 2015 Dec; 35(12):2575-83. PubMed ID: 25977117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preexisting atrial fibrillation and cardiac complications after liver transplantation.
    Bargehr J; Trejo-Gutierrez JF; Patel T; Rosser B; Aranda-Michel J; Yataco ML; Taner CB
    Liver Transpl; 2015 Mar; 21(3):314-20. PubMed ID: 25488693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography myocardial perfusion imaging (PET MPI) findings predictive of post-liver transplant major adverse cardiac events.
    Hughes DL; Pan J; Answine AR; Sonnenday CJ; Waits SA; Kumar SS; Menees DS; Wanamaker B; Bhave NM; Tincopa MA; Fontana RJ; Sharma P
    Liver Transpl; 2023 Sep; 29(9):970-978. PubMed ID: 36879556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and incidence of stroke and MACE in Chinese atrial fibrillation patients presenting to emergency departments: a national wide database analysis.
    Yang YM; Shao XH; Zhu J; Zhang H; Liu Y; Gao X; Liu LS; Yu LT; Zhao L; Yu PF; Zhang H; He Q; Gu XD
    Int J Cardiol; 2014 May; 173(2):242-7. PubMed ID: 24630382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score.
    Polovina M; Đikić D; Vlajković A; Vilotijević M; Milinković I; Ašanin M; Ostojić M; Coats AJS; Seferović PM
    Int J Cardiol; 2017 Dec; 249():191-197. PubMed ID: 28986061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
    Piazza NA; Singal AK
    Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcome in Patients With Heart Failure Treated With Levothyroxine: An Observational Nationwide Cohort Study.
    Einfeldt MN; Olsen AS; Kristensen SL; Khalid U; Faber J; Torp-Pedersen C; Gislason GH; Selmer C
    J Clin Endocrinol Metab; 2019 May; 104(5):1725-1734. PubMed ID: 30517746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation.
    Salvalaggio PR; Dzebisashvili N; MacLeod KE; Lentine KL; Gheorghian A; Schnitzler MA; Hohmann S; Segev DL; Gentry SE; Axelrod DA
    Liver Transpl; 2011 Mar; 17(3):233-42. PubMed ID: 21384505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Perioperative Cardiovascular Events in Liver Transplantation.
    Koshy AN; Farouque O; Cailes B; Ko J; Han HC; Weinberg L; Testro A; Robertson M; Teh AW; Lim HS; Gow PJ
    Transplantation; 2021 Mar; 105(3):593-601. PubMed ID: 32413014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative Atrial Fibrillation and Long-Term Risk of Stroke in Patients Undergoing Liver Transplantation.
    Koshy AN; Enyati A; Weinberg L; Han HC; Horrigan M; Gow PJ; Ko J; Thijs V; Testro A; Lim HS; Farouque O; Teh AW
    Stroke; 2021 Jan; 52(1):111-120. PubMed ID: 33349017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerosis on CT coronary angiography and the risk of long-term cardiovascular events after liver transplantation.
    Sampaio Rodrigues T; Koshy AN; Gow PJ; Weinberg L; Cailes B; Testro A; Smith G; Lim HS; Teh AW; Lim RP; Farouque O
    Liver Transpl; 2024 Feb; 30(2):182-191. PubMed ID: 37432891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular filtration rate early after liver transplantation independently predicts atherosclerotic events.
    Hassouneh R; Patel S; Shen S; Bui A; Syed T; Flynn S; Patel V; Muthiah MD; Sharma A; Bhati C; Siddiqui MS
    Liver Transpl; 2022 Jul; 28(7):1186-1195. PubMed ID: 35124881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
    Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
    JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation.
    Polovina M; Hindricks G; Maggioni A; Piepoli M; Vardas P; Ašanin M; Ðikic D; Ðuricic N; Milinkovic I; Seferovic PM
    Eur Heart J; 2018 Dec; 39(45):4030-4039. PubMed ID: 30101326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analysis on the impact of pre-existing and new-onset atrial fibrillation on outcomes before and after liver transplantation.
    So WZ; Tan FL; Tan DJH; Ng CH; Yong JN; Syn N; Tang ASP; Wong RC; Lin W; Tan EXX; Huang DQ; Dan YY; Chew NWS; Siddiqui MS; Muthiah MD
    Dig Liver Dis; 2022 May; 54(5):614-621. PubMed ID: 34896025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.